Science Explorer Back to mapMap

Most cited papers from TScan Therapeutics (United States)

What are the most cited papers from TScan Therapeutics (United States)?

The most cited paper from TScan Therapeutics (United States) is "Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma" (Giacomo Oliveira et al., 2021), with 584 citations. Next come "Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy" (399) and "Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein" (367).

Showing 23 of 23 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma Giacomo Oliveira et al. · Nature Open access 21 Jul 2021 584
2 Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy Adrienne Luoma et al. · Cell Open access 7 Jul 2022 399
3 Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein Andrew P. Ferretti, Tomasz Kula, Yifan Wang et al. · Immunity Open access 20 Oct 2020 367
4 Development of spirulina for the manufacture and oral delivery of protein therapeutics Benjamin W. Jester et al. · Nature Biotechnology Open access 21 Mar 2022 126
5 Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine Apostolia Maria Tsimberidou, David S. Hong, Jennifer J. Wheler et al. · Journal of Hematology & Oncology Open access Dec 2019 82
6 HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy Qinqin Jiang et al. · Cell Open access 28 Feb 2025 66
7 Report of the First International Symposium on NUT Carcinoma Christopher A. French et al. · Clinical Cancer Research Open access 13 Apr 2022 58
8 Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods Hemangi G. Chaudhari, Jon Penterman, Holly J. Whitton et al. · The CRISPR Journal Open access Dec 2020 50
9 Report of the First International Symposium on NUT Carcinoma Christopher Alexander French et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) 2022 42
10 COVID-19 Patients Form Memory CD8+ T Cells that Recognize a Small Set of Shared Immunodominant Epitopes in SARS-CoV-2 Andrew P. Ferretti, Tomasz Kula, Yifan Wang et al. · medRxiv PreprintOpen access 27 Jul 2020 22
11 International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell–based genomic therapies and the challenges faced Ashish O. Gupta, Melissa Azul, Senthil Velan Bhoopalan et al. · Cytotherapy Open access 6 Jun 2024 17
12 Prediction of whole-cell transcriptional response with machine learning Mohammed Eslami et al. · Bioinformatics Open access 22 Sep 2021 16
13 The Effect of Antinociceptive Drugs Tested at Different Times After Nerve Injury in Rats Aldric T. Hama, David Borsook · Anesthesia & Analgesia 17 Jun 2005 16
14 Online monitoring and control of upstream cell culture process using 1D and 2D‐LC with SegFlow interface Letha Chemmalil, Dhanuka P. Wasalathanthri, Xin Zhang et al. · Biotechnology and Bioengineering 29 Jun 2021 12
15 Expression and manufacturing of protein therapeutics in spirulina Benjamin W. Jester et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 27 Jan 2021 9
16 A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics Miriam Elsa Meyer et al. · Nature Reviews Drug Discovery 29 Nov 2023 6
17 A toolkit for enhanced reproducibility of RNASeq analysis for synthetic biologists Benjamin J. Garcia, Joshua A. Urrutia, George Zheng et al. · Synthetic Biology Open access Feb 2022 5
18 Micro-Chimerism Detected By Highly Sensitive AlloHemeTM Solution Is Associated with Treatment Response and Relapse after Allogeneic Stem Cell Transplantation Ashish S Kothari, Nishant Dwivedi, Shrikanta Chattopadhyay et al. · Transplantation and Cellular Therapy Open access Feb 2024 1
19 Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation Ran Reshef, Hyung Chan Suh, Monzr M. Al Malki et al. · Blood 15 Nov 2022 1
20 Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer David Glen Coffey, Yuexin Xu, Andrea M. H. Towlerton et al. · Frontiers in Immunology Open access 9 Sep 2022 1
21 Immunologic Basis of Immuno-therapeutics and Vaccines: Present Approaches and Future Perspectives Alok Das Mohapatra, Priyadarshi Soumyaranjan Sahu · Interdisciplinary biotechnological advances Book chapter 2024 0
22 Assays to Detect Cross-Dressing by Dendritic Cells In Vivo and In Vitro Alok Das Mohapatra, Pramod Kumar Srivastava · Methods in molecular biology Book chapter 2023 0
23 Biotech leaders call for free press Ron Cohen et al. · Nature Biotechnology 170 authors Oct 2018 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.